Published ahead of print on June 16, 2004, doi:10.1164/rccm.200310-1434OC
Am. J. Respir. Crit. Care Med., Volume 170, Number 7, October 2004, 766-772
A more recent version of this article appeared on October 1, 2004
Submitted on October 21, 2003
Accepted on June 15, 2004
Significance of von Willebrand Factor in Septic and Non-septic Patients with Acute Lung Injury
Lorraine B Ware1*, Mark D Eisner2, B. Taylor Thompson3, Polly Parsons4, Michael A Matthay5, and The Acute Respiratory Distress Syndrome Network
1 Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA,
2 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA, USA; Division of Occupational and Environmental Medicine, Department of Medicine, University of California, San Francisco, CA, USA,
3 Pulmonary/Critical Care Unit and ARDS Network Clinical Coordinating Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA,
4 Division of Pulmonary and Critical Care Medicine, Department of Medicine, Fletcher Allen Health Care, University of Vermont, Burlington, VT, USA,
5 Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California, San Francisco, CA, USA; Department of Anesthesia and Cardiovascular Research Institute, University of California, San Francisco, CA, USA
* To whom correspondence should be addressed. E-mail: lorraine.ware{at}vanderbilt.edu.
Systemic endothelial activation and injury are important causes of multi-organ system failure. We hypothesized that plasma levels of von Willebrand factor (VWF), a marker of endothelial activation and injury, would be associated with clinical outcomes in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). In 559 ALI/ARDS patients enrolled in the NHLBI ARDS Network trial of two tidal volume strategies, plasma VWF levels were measured at randomization (mean 350 ± 265% of normal controls) and day 3 (344 ± 207%). Baseline VWF levels were similar in patients with and without sepsis and were significantly higher in non-survivors (435 ± 333%) versus survivors (306 ±209 %) even when controlling for severity of illness, sepsis and ventilator strategy (increased OR of death of 1.6 per SD-size increase in VWF, 95% CI 1.4-2.1). Higher VWF levels were also significantly associated with fewer organ-failure free days. Ventilator strategy had no effect on VWF levels. In conclusion, the degree of endothelial activation and injury is strongly associated with outcomes in ALI/ARDS regardless of the presence or absence of sepsis and is not modulated by a protective ventilatory strategy. To further improve outcomes, new treatment strategies targeted at the endothelium should be investigated.
Key words: von Willebrand factor, ARDS, sepsis
This article has been cited by other articles:

|
 |

|
 |
 
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med,
May 1, 2009;
24(3):
151 - 167.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Levitt, H. Bedi, C. S. Calfee, M. K. Gould, and M. A. Matthay
Identification of Early Acute Lung Injury at Initial Evaluation in an Acute Care Setting Prior to the Onset of Respiratory Failure
Chest,
April 1, 2009;
135(4):
936 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. X. L. Zhang, J. J. Miller, D. B. Stolz, L. D. Serpero, W. Zhao, D. Gozal, and Y. Wang
Type I Epithelial Cells Are the Main Target of Whole-Body Hypoxic Preconditioning in the Lung
Am. J. Respir. Cell Mol. Biol.,
March 1, 2009;
40(3):
332 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Farley, L. Wang, and S. Mehta
Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase
Am J Physiol Lung Cell Mol Physiol,
March 1, 2009;
296(3):
L480 - L488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Briot, J. A. Frank, T. Uchida, J. W. Lee, C. S. Calfee, and M. A. Matthay
Elevated Levels of the Receptor for Advanced Glycation End Products, a Marker of Alveolar Epithelial Type I Cell Injury, Predict Impaired Alveolar Fluid Clearance in Isolated Perfused Human Lungs
Chest,
February 1, 2009;
135(2):
269 - 275.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M van der Heijden, G P van Nieuw Amerongen, P Koolwijk, V W M van Hinsbergh, and A B J Groeneveld
Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients
Thorax,
October 1, 2008;
63(10):
903 - 909.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Liu and M. A. Matthay
Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS
Clin. J. Am. Soc. Nephrol.,
March 1, 2008;
3(2):
578 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Frank, P. E. Parsons, and M. A. Matthay
Pathogenetic Significance of Biological Markers of Ventilator-Associated Lung Injury in Experimental and Clinical Studies
Chest,
December 1, 2006;
130(6):
1906 - 1914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. McClintock, B. Starcher, M. D. Eisner, B. T. Thompson, D. L. Hayden, G. D. Church, M. A. Matthay, and the National Heart, Lung, Blood Institute Acute Re
Higher urine desmosine levels are associated with mortality in patients with acute lung injury
Am J Physiol Lung Cell Mol Physiol,
October 1, 2006;
291(4):
L566 - L571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Kawut, E. M. Horn, K. K. Berekashvili, A. C. Widlitz, E. B. Rosenzweig, and R. J. Barst
von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension
Chest,
October 1, 2005;
128(4):
2355 - 2362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Bernard
Acute Respiratory Distress Syndrome: A Historical Perspective
Am. J. Respir. Crit. Care Med.,
October 1, 2005;
172(7):
798 - 806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Angus, A. Ishizaka, M. Matthay, F. Lemaire, W. MacNee, and E. Abraham
Critical Care in AJRCCM 2004
Am. J. Respir. Crit. Care Med.,
March 15, 2005;
171(6):
537 - 544.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nagasaki, M. Inaba, S. Jono, Y. Hiura, H. Tahara, K. Shirakawa, N. Onoda, T. Ishikawa, E. Ishimura, and Y. Nishizawa
Increased levels of serum osteoprotegerin in hypothyroid patients and its normalization with restoration of normal thyroid function
Eur. J. Endocrinol.,
March 1, 2005;
152(3):
347 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|